Science Market Update

Texas A&M: Funding, Stroke Research, and Upcoming Event

Posted by Andrea Inks on Mon, Nov 12, 2018

With Research Expenditures of More Than $892.7 Million, Texas A&M's Division of Research delivers strategic support to advance the University's research mission through:

As a top tier research university with global recognition Texas A&M's Division of Research delivers strategic support to advance the University's research mission through:

  • enabling collaborations to increase federal fundingIMG_0717
  • strengthening the research organization
  • supporting the basic research programs
  • encouraging commercialization and research partnerships
  • ensuring research compliance

Recently, a grant from the NIH for over $2.8 million was recently awarded to Texas A&M and project leader Farida Sohrabji to study Epigenetics of The Aging Astrocyte: Implications for Stroke.

Dr Sohrabji focuses her research on “brain-immune interactions regulated by estrogen and its implications for neuro-inflammatory diseases such as stoke in women.” She is particularly interested in the way strokes are manifested differently between males and females. When young, females and males are equally unlikely to experience a stroke. After the age of 50, women are similarly likely to suffer a stroke as compared to men. As people age older, many more women will get a stroke as compared to men. These strokes tend to be worse on the women with greater mortality, disability and loss of independence.

0-cus-d3-ff2bd71e3c682acbd544d346cd1b94ad

Diseases and disabilities such as epilepsy, addiction, and depression can often be a result of stroke effect, which can be altered by environmental and developmental factors. Dr Sohrabji and her group are uncovering and testing drugs that can increase survival of neurons after stroke and reduce stroke-related disabilities.

“Stroke therapies: We are discovering and testing drugs that can increase survival of neurons after stroke and reduce stroke-related disability. These compounds include peptide hormones, non-coding RNA and histone modifiers. Interestingly, many of these novel therapies are effective only in one sex.”

This is one of many import research studies happening at Texas A&M University, a multi-million dollar research market where life science researchers are actively looking for new products and technologies to help with their research programs.

Finding new lab products for current research needs...

Every year, Biotechnology Calendar, Inc. produces an annual BioResearch Product Faire™ event at TAMU as an opportunity for lab product supply companies to meet with active researchers, and to help them source the best new products.

Come connect with groundbreaking researchers at Texas A&M, join us at:

Texas A&M University BioResearch Product Faire™ Event – 1/30/2019

Lab Suppliers and service providers will want to participate in this popular event and become a part of this valuable, life science community event.

 

Get UCLA funding stats

 

texas-am

"Researchers were so enthusiastic about what we had to offer it really made the event successful for us.” – Exhibitor, Texas A & M University Event

"Being at this show has made a significant difference in our business. I look forward to being there every year. – Exhibitor, Texas A&M University BCI event

See for yourself why exhibiting at our event increases your bottom line. Be part of this innovative community and connect with groundbreaking researchers at Texas A&M join us at:

Texas A&M University BioResearch Product Faire™ Event – 1/30/2019

Click Here to Exhibit at Texas  A&M University

Ranked in the top 20 of the National Science Foundation’s Higher Education Research and Development survey with over $892 million in expenditures in fiscal year 2016 the Texas A&M Event is sure to be a sell out.

Texas: TAMU $892 Million + in Expenditures

 

 

 

 

Tags: TX, BIO5 Institute, John Hopkins

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News